Home › Funds › Aristotle Atlantic Partners, LLC › GH

Aristotle Atlantic Partners, LLC position in GH

GUARDANT HEALTH INC · Health Care

Aristotle Atlantic Partners, LLC reported holding 429,605 shares of GH (GUARDANT HEALTH INC) in its Q3 2026 13F filing — a position valued at US$76.6M, representing 2.99% of its reported portfolio and ranking #8 among its reported holdings. Aristotle Atlantic Partners, LLC has disclosed GH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)429.61K sh
Reported value held$76.62M
Portfolio Weight2.99%
First reportedQ3 2023
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Aristotle Atlantic Partners, LLC's GH position evolved

Aristotle Atlantic Partners, LLC first disclosed a stake in GH in Q3 2023 at 834,096 shares (US$24.7M). The position peaked in Q3 2026 at 429,605 shares, worth US$76.6M. Across 13 filings, Aristotle Atlantic Partners, LLC increased the stake 2 time(s), trimmed it 9 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 429,605 shares valued at US$76.6M — a reduction of -13,211 shares quarter over quarter.. Notable position changes include a 46% trim in Q4 2025 (shares fell 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 834.10K $24.72M New
Q4 2023 836.95K $22.64M Hold
Q1 2024 806.89K $16.65M Reduce
Q2 2024 749.20K $21.64M Reduce
Q3 2024 893.51K $20.50M Add
Q4 2024 852.00K $26.03M Reduce
Q1 2025 964.52K $41.09M Add
Q2 2025 931.96K $48.50M Reduce
Q3 2025 923.73K $57.71M Reduce
Q4 2025 494.39K $50.50M Reduce
Q1 2026 445.53K $41.15M Reduce
Q2 2026 442.82K $66.44M Reduce
Q3 2026 429.61K $76.62M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GH and 13F data

GH (GUARDANT HEALTH INC) is a Health Care company. 59 other funds we track also report a position in GH — the largest reported positions include Deep Track Capital, LP (US$500.4M), FEDERATED HERMES, INC. (US$445.6M), EVENTIDE ASSET MANAGEMENT, LLC (US$331.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GH

All GH fund holders →

FAQ

How long has Aristotle Atlantic Partners, LLC held GH?

Aristotle Atlantic Partners, LLC has disclosed GH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Aristotle Atlantic Partners, LLC's current position in GH?

As of Q3 2026, Aristotle Atlantic Partners, LLC holds 429.61K shares of GH (GUARDANT HEALTH INC), valued at $76.62M, representing 2.99% of its reported portfolio and ranking #8.

Has Aristotle Atlantic Partners, LLC been buying or selling GH?

In the latest 13F filing (Q3 2026), Aristotle Atlantic Partners, LLC reduced its position in GH. The position peaked in Q3 2026 at 429.61K shares.

Which other funds hold GH?

Other major institutional holders of GH include Deep Track Capital, LP, FEDERATED HERMES, INC., EVENTIDE ASSET MANAGEMENT, LLC, among 59 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.